In-Person and Telehealth Provider Access and Glycemic Control for People With Diabetes During the COVID-19 Pandemic
Authors' conclusion
Findings support continued use of telehealth, and we anticipate hybrid models of care will be utilized for people with diabetes beyond the pandemic.
Study context
- Population
- All patients with diabetes established with a provider at a large academic medical center
- Exposure
- COVID period vs pre-COVID period
- Outcome
- Ambulatory provider visits (in-person and telehealth)
Methodological detailssingle academic medical center
- Single academic medical center
Main finding
As reported in the abstract
- Number of people with diabetes with any ambulatory provider visit decreased during the COVID period
- Telehealth saw massive growth
Observational data: associations, not effects.
Further findings
- Glycemic control by HbA1c remained stable from pre-COVID to COVID period
Original publication
In-Person and Telehealth Provider Access and Glycemic Control for People With Diabetes During the COVID-19 Pandemic. J Diabetes Sci Technol. Published 30 March 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →